$TSOI
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi

$tsoi Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224033098 Filed on August 19, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$19.67K	$20.01K
YoY Change	-23.56%	-23.96%
Cost Of Revenue	$4.409K	$6.727K
YoY Change	-37.48%	-37.12%
Gross Profit	$15.26K	$13.28K
YoY Change	-18.31%	-14.93%
Gross Profit Margin	77.58%	66.37%
Selling, General & Admin		$399.8K
YoY Change		14.35%
% of Gross Profit		3010.62%
Research & Development	$16.05K	$17.57K
YoY Change	-89.22%	-91.57%
% of Gross Profit	105.21%	132.32%
Depreciation & Amortization		$76.92K
YoY Change		0.0%
% of Gross Profit		579.3%
Operating Expenses	$1.975M	$417.3K
YoY Change	314.86%	-25.23%
Operating Profit	-$1.960M	-$404.0K
YoY Change	328.47%	-25.52%
Interest Expense		-$59.52K
YoY Change		-148.68%
% of Operating Profit
Other Income/Expense, Net	-$75.91K	-$59.52K
YoY Change	-47.84%	198.34%
Pretax Income	-$2.035M	-$463.6K
YoY Change	237.63%	-17.58%
Income Tax		$800.00
% Of Pretax Income
Net Earnings	-$1.008M	-$390.0K
YoY Change	67.35%	-30.65%
Net Earnings / Revenue	-5122.97%	-1949.74%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	4.884B shares	4.230B shares
Diluted Shares Outstanding	4.913B shares	4.512B shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$8.320K
YoY Change		-93.24%
Cash & Equivalents	$9.233K	$8.318K
Short-Term Investments
Other Short-Term Assets	$2.479M	$2.554M
YoY Change	6098.71%	4923.95%
Inventory	$17.15K	$17.81K
Prepaid Expenses	$10.74K	$15.08K
Receivables	$17.04K	$17.29K
Other Receivables		$0.00
Total Short-Term Assets	$498.7K	$736.3K
YoY Change	175.58%	230.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$366.2K	$368.9K
YoY Change	-2.89%	37.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.630M	$2.558M
YoY Change	-5.55%	-10.52%
Total Long-Term Assets	$3.102M	$3.039M
YoY Change	-5.82%	-6.91%
TOTAL ASSETS
Total Short-Term Assets	$498.7K	$736.3K
Total Long-Term Assets	$3.102M	$3.039M
Total Assets	$3.600M	$3.775M
YoY Change	3.63%	8.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$376.9K
YoY Change		3.95%
Accrued Expenses	$571.7K	$553.7K
YoY Change	-4.95%	-2.84%
Deferred Revenue
YoY Change
Short-Term Debt		$841.8K
YoY Change		13.23%
Long-Term Debt Due		$4.640K
YoY Change		0.0%
Total Short-Term Liabilities	$1.839M	$1.850M
YoY Change	-10.45%	-1.31%
LONG-TERM LIABILITIES
Long-Term Debt		$3.220K
YoY Change		-60.15%
Other Long-Term Liabilities		$85.93K
YoY Change		-24.32%
Total Long-Term Liabilities		$89.15K
YoY Change		-26.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.839M	$1.850M
Total Long-Term Liabilities		$89.15K
Total Liabilities	$1.919M	$1.939M
YoY Change	-11.38%	-2.85%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.31M	-$21.30M
YoY Change	14.91%	13.23%
Common Stock	$5.057M	$4.659M
YoY Change	46.56%	48.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.238M	$1.314M
YoY Change
Total Liabilities & Shareholders Equity	$3.600M	$3.775M
YoY Change	3.63%	8.25%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$1.008M	-$390.0K
YoY Change	67.35%	-30.65%
Depreciation, Depletion And Amortization		$76.92K
YoY Change		0.0%
Cash From Operating Activities		-$143.4K
YoY Change		-57.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		98.26K
YoY Change		-77.33%
NET CHANGE
Cash From Operating Activities		-143.4K
Cash From Investing Activities
Cash From Financing Activities		98.26K
Net Change In Cash		-45.15K
YoY Change		-148.26%
FREE CASH FLOW
Cash From Operating Activities		-$143.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54554
	dei	Entity Registrant Name EntityRegistrantName	Therapeutic Solutions International, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-1226465
	dei	Entity Address Address Line1 EntityAddressAddressLine1	701 Wild Rose Lane
	dei	Entity Address City Or Town EntityAddressCityOrTown	Elk City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	ID
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	83525
	dei	City Area Code CityAreaCode	(760)
	dei	Local Phone Number LocalPhoneNumber	295-7208
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001419051
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q2	TSOI	Stock Issued During Period Value For Prepaid Fees StockIssuedDuringPeriodValueForPrepaidFees		usd
CY2023Q2	TSOI	Stock Issued During Period Values For Salaries StockIssuedDuringPeriodValuesForSalaries		usd
CY2023Q2	TSOI	Stock Issued During Period Value Relief Of Derivative Liabilities StockIssuedDuringPeriodValueReliefOfDerivativeLiabilities		usd
CY2023Q2	TSOI	Stock Issued During Period Value Common Stock Issued StockIssuedDuringPeriodValueCommonStockIssued		usd
CY2023Q2	TSOI	Stock Issued During Period Value Benefical Conversion Feature On Notes Payable StockIssuedDuringPeriodValueBeneficalConversionFeatureOnNotesPayable		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	TSOI	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4884095275	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27823	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19196	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	22574	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16320	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	85913	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	374355	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	125557	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2706187	usd
CY2023Q4	us-gaap	Assets Assets	3292012	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	536118	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20525	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	48554	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	112384	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	49616	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	181070	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1899586	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	5512	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	105032	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2010130	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5500000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4659017624	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4659017624	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3802666978	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3802666978	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3802668	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17670092	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	21000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20326465	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1125295	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	156587	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1281882	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3292012	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	49431	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19165	usd
	us-gaap	Gross Profit GrossProfit	30266	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	232744	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	224479	usd
	us-gaap	Professional Fees ProfessionalFees	122757	usd
	us-gaap	Legal Fees LegalFees	161392	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	261267	usd
	us-gaap	Operating Expenses OperatingExpenses	1002639	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-972373	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	24275	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-33712	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	244073	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	85546	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	85546	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-167964	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1140337	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
	us-gaap	Profit Loss ProfitLoss	-1141137	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-856	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1140281	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4511799474	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4511799474	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2976127083	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2976127083	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4232658617	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4232658617	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2834408024	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2834408024	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1385181	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	79600	usd
	TSOI	Stock Issued During Period Values For Salaries StockIssuedDuringPeriodValuesForSalaries	20000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	488352	usd
	TSOI	Adjustments To Additional Paid In Capital Subsidiary For Services AdjustmentsToAdditionalPaidInCapitalSubsidiaryForServices	1831	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	657719	usd
	us-gaap	Profit Loss ProfitLoss	-1141137	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1491546	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1165445	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	60000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	358266	usd
CY2023Q2	TSOI	Adjustments To Additional Paid In Capital Subsidiary For Services AdjustmentsToAdditionalPaidInCapitalSubsidiaryForServices	1831	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	469260	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-563256	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1491546	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1281882	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	64400	usd
	TSOI	Stock Issued During Period Value For Prepaid Fees StockIssuedDuringPeriodValueForPrepaidFees	20000	usd
	TSOI	Stock Issued During Period Values For Salaries StockIssuedDuringPeriodValuesForSalaries	60000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	183853	usd
	TSOI	Stock Issued During Period Value New Issues Preferred Stock StockIssuedDuringPeriodValueNewIssuesPreferredStock	10000	usd
	TSOI	Adjustments To Additional Paid In Capital Subsidiary For Services AdjustmentsToAdditionalPaidInCapitalSubsidiaryForServices	1125000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	319293	usd
	us-gaap	Profit Loss ProfitLoss	-1228625	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1835803	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2005375	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2005375	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	18500	usd
CY2024Q2	TSOI	Stock Issued During Period Values For Salaries StockIssuedDuringPeriodValuesForSalaries	60000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	34762	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	181523	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-464357	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1835803	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1835803	usd
	us-gaap	Profit Loss ProfitLoss	-1228625	usd
	us-gaap	Profit Loss ProfitLoss	-1141137	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1146600	usd
	TSOI	Share Based Compensation To Related Parties ShareBasedCompensationToRelatedParties	42800	usd
	TSOI	Share Based Compensation To Related Parties ShareBasedCompensationToRelatedParties	79600	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-13826	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	24275	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	26483	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-33712	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	85546	usd
	TSOI	Amortization Of Prepaid Stock Based Compensation AmortizationOfPrepaidStockBasedCompensation	14204	usd
	TSOI	Amortization Of Prepaid Stock Based Compensation AmortizationOfPrepaidStockBasedCompensation	101162	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	139630	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	221686	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	148387	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	148387	usd
	us-gaap	Depreciation Depreciation	5441	usd
	us-gaap	Depreciation Depreciation	5441	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1907	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7819	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4768	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-11036	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	671032	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-70528	usd
	TSOI	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	13709	usd
	TSOI	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	16654	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-31453	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-46615	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	3481	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-6	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	87627	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	80026	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-13709	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-16654	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-348922	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-538182	usd
	TSOI	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable	800	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-800	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	9	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	12	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	7869	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3360	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	130000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	143750	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2296	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2428	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	10000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	183853	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	488352	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	329417	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	633022	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19505	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	94040	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	27823	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	29043	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8318	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	123083	usd
	us-gaap	Interest Paid Net InterestPaidNet	1132	usd
	us-gaap	Interest Paid Net InterestPaidNet	2091	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	800	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	800	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	45800	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	17500	usd
	TSOI	Debt Discount Recorded In Connection With Derivative Liability DebtDiscountRecordedInConnectionWithDerivativeLiability	30000	usd
	TSOI	Debt Discount Recorded In Connection With Derivative Liability DebtDiscountRecordedInConnectionWithDerivativeLiability	142565	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	319293	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	657719	usd
	TSOI	Common Stock Issued For Prepaid Fees Value CommonStockIssuedForPrepaidFeesValue	20000	usd
	TSOI	Common Stock Issued For Prepaid Fees Value CommonStockIssuedForPrepaidFeesValue	1831	usd
	TSOI	Common Stock Issued For Accrued Salaries Value CommonStockIssuedForAccruedSalariesValue	60000	usd
	TSOI	Common Stock Issued For Accrued Salaries Value CommonStockIssuedForAccruedSalariesValue	20000	usd
	TSOI	Accrued Interest Added To Principal AccruedInterestAddedToPrincipal	3956	usd
	TSOI	Accrued Interest Added To Principal AccruedInterestAddedToPrincipal	9170	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	146244	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2007-08-06
CY2024Q2	TSOI	Losses For Period LossesForPeriod	-21300000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10647	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6807	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41819	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	49431	usd
	TSOI	Wholesale Purchase Price And Payments Description WholesalePurchasePriceAndPaymentsDescription	Seller agrees to sell the Goods to Buyer for Fifty Percent (50%) off Sellers listed retail price. Seller will provide an invoice to Buyer at the time of delivery. All invoices must be paid, in full, within thirty (30) days. Any balances not paid within thirty (30) days will be subject to a five percent (5%) late payment penalty. In the event Buyer exceeds the aggregate of $500,000 worth of aforementioned products having been purchased, delivered, and paid for, Buyer will be entitled to an additional Five Percent (5%) discount up to the aggregate of $750,000.00. In the event Buyer exceeds the aggregate of $750,000 worth of aforementioned products having been purchased, delivered, and paid for, Buyer will be entitled to an additional Five Percent (5%) discount up to the aggregate of $1,500,000.00. All future sales after an initial $1,500,000 in aggregate purchases will be sold at 60% off retail
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	47220	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	181070	usd
CY2023Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	181070	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	85264	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet	-192631	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	-26483	usd
CY2024Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	47220	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zOFyaZg1QTtg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_z2yF42Nu1Gg2">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates were made relating to valuation allowances, impairment of assets, share-based compensation expense and accruals. Actual results could differ materially from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1605641025	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	586973744	shares
	us-gaap	Depreciation Depreciation	5441	usd
	us-gaap	Depreciation Depreciation	5441	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	148387	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	148387	usd
	us-gaap	Advertising Expense AdvertisingExpense	696	usd
	us-gaap	Advertising Expense AdvertisingExpense	1084	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	76182	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	261267	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	111848	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	15083	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11037	usd
CY2024Q2	us-gaap	Prepaid Insurance PrepaidInsurance	613	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1167	usd
CY2024Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	677161	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4116	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	692857	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16320	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	413517	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	413517	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	44602	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	39162	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	368915	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	374355	usd
	us-gaap	Depreciation Depreciation	5441	usd
	us-gaap	Depreciation Depreciation	5441	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2553676	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2702064	usd
CY2024Q2	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	292	usd
CY2024Q2	us-gaap	Deposit Assets DepositAssets	4123	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	4123	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2558091	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2706187	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3261122	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3261122	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	707446	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	559058	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2553676	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2702064	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	148387	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	148387	usd
	us-gaap	Payments Of Derivative Issuance Costs PaymentsOfDerivativeIssuanceCosts	85264	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4659017624	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4659017624	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1002	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1002	shares
	TSOI	Stock Issued During Period Shares For Salaries StockIssuedDuringPeriodSharesForSalaries	80357142	shares
	TSOI	Stock Issued During Period Values For Salaries StockIssuedDuringPeriodValuesForSalaries	60000	usd
	TSOI	Stock Issued During Period Shares For Prepaid Fees StockIssuedDuringPeriodSharesForPrepaidFees	20000000	shares
	TSOI	Stock Issued During Period Value For Prepaid Fees StockIssuedDuringPeriodValueForPrepaidFees	20000	usd
CY2024Q1	TSOI	Preferred Stock Stated Percentage PreferredStockStatedPercentage	1	pure
CY2024Q1	TSOI	Debt Instrument Threshold Trading Days DebtInstrumentThresholdTradingDays	P20D
CY2024Q2	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	1745366.27	usd
CY2023Q1	us-gaap	Area Of Land AreaOfLand	1700	sqft
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P60M
CY2023Q1	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2028-04-30
	us-gaap	Payments For Rent PaymentsForRent	12846	usd
	us-gaap	Payments For Rent PaymentsForRent	12604	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.011	pure

Files In Submission

Name	View Source	Status
0001493152-24-033098-index-headers.html	Edgar Link	pending
0001493152-24-033098-index.html	Edgar Link	pending
0001493152-24-033098.txt	Edgar Link	pending
0001493152-24-033098-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tsoi-20240630.xsd	Edgar Link	pending
tsoi-20240630_cal.xml	Edgar Link	unprocessable
tsoi-20240630_def.xml	Edgar Link	unprocessable
tsoi-20240630_lab.xml	Edgar Link	unprocessable
tsoi-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TSOI
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi

2024 Q3 Form 10-Q Financial Statement

#000149315224033098 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSOI THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi

2024 Q3 Form 10-Q Financial Statement

#000149315224033098 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSOI
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi